Lakeland Industries Inc
LAKE Nasdaq Orthopedic, Prosthetic & Surgical Appliances & Supplies Financials FY2015βFY2026
What Lakeland Industries Inc does
No business description yet.
- Legal name
- LAKELAND INDUSTRIES INC
- Fiscal year ends
- January 31, 2026
- Latest annual report
- 10-K Β· Apr 16, 2026
- Accession Β· CIK
- 0001193125-26-159176
0000798081
Revenue and margins
Lakeland Industries Inc had $193M of revenue in fiscal 2026, up 70.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$16.4M in fiscal 2026, β8.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Lakeland Industries Inc returned $1.2M to shareholders in fiscal 2026. The diluted share count rose 24.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Lakeland Industries Inc can carry it.
| Fiscal year end | FY20 | FY21 | FY22 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $14.6M | $52.6M | $52.7M | $17.5M | $12.5M |
| Debt incl. finance leases | $1.2M | $0.0M | $0.0M | $17.4M | $30.4M |
| Net debt / EBITDA | β1.8x | β1.1x | β2.9x | β0.0x | β |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.1x | 0.2x |
| Interest coverage | 50.7x | 1,908.1x | 1,069.8x | 149.8x | β7.2x |
| Current ratio | 6.2x | 7.6x | 10.0x | 3.9x | 3.5x |
| Quick ratio | 2.7x | 4.9x | 6.1x | 1.5x | 1.4x |
| Total assets | $99.4M | $140M | $141M | $213M | $210M |
| Total liabilities | $14.4M | $17.8M | $15.7M | $65.9M | $80.8M |
| Shareholders' equity | $85.1M | $122M | $125M | $147M | $129M |
| Net debt (β = net cash) | β$13.5M | β$52.6M | β$52.7M | β$0.1M | $17.9M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY15 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 9 | 7 / 9 | 6 / 9 | 6 / 9 | 8 / 9 | 8 / 9 | 5 / 9 | β / 3 | 2 / 9 |
| Accruals ratio | 5.4% | 4.8% | β8.8% | β0.2% | β0.3% | β0.3% | β4.5% | β1.0% | 3.4% | β4.5% |
| Altman Z'' | 5.87 | 7.76 | 10.48 | 13.07 | 12.86 | 11.61 | 15.54 | 15.65 | 6.42 | 4.56 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY15 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $93.4M | $99.6M | $86.2M | $96.0M | $99.0M | $108M | $159M | $118M | $113M | $193M |
| Provision for credit losses | $0.0M | $2.3M | $0.0M | $0.0M | β | β | β | β | β | β |
| Gross profit | $31.7M | $36.3M | $31.6M | $36.2M | $33.9M | $37.9M | $79.3M | $50.9M | $45.8M | $63.3M |
| Research and development | $0.1M | $0.2M | $0.5M | $0.3M | $0.2M | $0.2M | $0.2M | β | β | β |
| Operating income | $7.0M | $11.8M | $6.8M | $8.5M | $3.6M | $5.9M | $43.9M | $16.0M | $5.5M | β$15.5M |
| Interest expense | $1.7M | $0.8M | $0.6M | $0.2M | $0.1M | $0.1M | $0.0M | $0.0M | $0.0M | $2.1M |
| Pretax income | $2.9M | $10.9M | $6.3M | $8.3M | $3.5M | $5.8M | $43.9M | $16.2M | $5.5M | β$17.7M |
| Income tax | β$8.2M | $3.1M | $2.4M | $7.9M | $2.0M | $2.5M | $8.6M | $4.8M | $3.6M | $7.6M |
| Net income | $8.4M | $3.9M | $3.9M | $0.4M | $1.5M | $3.3M | $35.3M | $11.4M | $1.9M | β$25.3M |
| Diluted EPS | $1.33 | $0.53 | $0.53 | $0.06 | $0.18 | $0.41 | $4.34 | $1.41 | $0.24 | β$2.63 |
| Diluted shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $3.3M | β$0.5M | $11.5M | $0.6M | $1.8M | $3.6M | $40.7M | $12.8M | β$5.5M | β$15.8M |
| Capital expenditure | $0.9M | $0.8M | $0.4M | $0.9M | $3.1M | $1.0M | $1.7M | $0.8M | $2.0M | $0.7M |
| Free cash flow | $2.4M | β$1.4M | $11.1M | β$0.3M | β$1.3M | $2.6M | $39.0M | $12.0M | β$7.4M | β$16.4M |
| Depreciation and amortization | $1.1M | $1.0M | $1.2M | $0.8M | $1.0M | $1.6M | $2.0M | $1.9M | $1.5M | $2.8M |
| Stock-based compensation | $1.2M | $0.6M | $0.3M | $0.4M | $0.7M | β$0.4M | $1.7M | $1.7M | $1.5M | $3.4M |
| Acquisitions | β | β | β | β | β | β | β | β | β | $6.2M |
| Dividends paid | β | β | β | β | β | β | β | β | β | $1.2M |
| Dividends and buybacks | β | β | β | β | β | β | β | β | β | $1.2M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $6.7M | $7.0M | $10.4M | $15.8M | $12.8M | $14.6M | $52.6M | $52.7M | $17.5M | $12.5M |
| Total debt | $12.4M | $16.7M | $5.9M | $1.9M | $1.3M | $1.2M | $0.0M | $0.0M | $17.4M | $30.4M |
| Current assets | $68.6M | $62.1M | $60.1M | $76.5M | $75.5M | $79.8M | $123M | $121M | $137M | $134M |
| Current liabilities | $26.2M | $20.0M | $12.3M | $10.4M | $10.3M | $12.9M | $16.2M | $12.0M | $34.9M | $38.0M |
| Inventory | $37.1M | $40.8M | $35.5M | $42.9M | $42.4M | $44.2M | $43.6M | $47.7M | $82.7M | $82.5M |
| Property and equipment, net | $10.1M | $9.3M | $8.5M | $8.8M | $10.8M | $10.1M | $9.8M | $8.7M | $13.9M | $11.6M |
| Goodwill | $0.9M | $0.9M | $0.9M | $0.9M | $0.9M | $0.9M | $0.9M | $0.9M | $16.2M | $15.3M |
| Intangible assets | $0.2M | $0.1M | β | β | β | β | β | $0.0M | $25.5M | $31.7M |
| Total assets | $93.2M | $88.3M | $84.6M | $94.5M | $94.7M | $99.4M | $140M | $141M | $213M | $210M |
| Total liabilities | $30.0M | $20.7M | $13.0M | $11.7M | $11.5M | $14.4M | $17.8M | $15.7M | $65.9M | $80.8M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $63.3M | $67.5M | $71.5M | $82.8M | $83.2M | $85.1M | $122M | $125M | $147M | $129M |
| Margins | ||||||||||
| Gross margin | 33.9% | 36.5% | 36.7% | 37.7% | 34.2% | 35.2% | 49.9% | 43.0% | 40.6% | 32.9% |
| Operating margin | 7.5% | 11.9% | 7.9% | 8.8% | 3.6% | 5.5% | 27.6% | 13.6% | 4.9% | β8.1% |
| EBITDA margin | 8.6% | 12.8% | 9.3% | 9.6% | 4.6% | 7.0% | 28.8% | 15.1% | 6.2% | β6.6% |
| Net margin | 9.0% | 3.9% | 4.5% | 0.5% | 1.5% | 3.0% | 22.2% | 9.6% | 1.7% | β13.1% |
| FCF margin | 2.6% | β1.4% | 12.9% | β0.3% | β1.3% | 2.4% | 24.5% | 10.1% | β6.6% | β8.5% |
| Returns | ||||||||||
| Return on capital | 10.1% | 10.9% | 6.6% | 8.0% | 3.2% | 5.3% | 51.1% | 15.6% | 2.5% | β8.3% |
| Return on capital employed | 10.4% | 17.3% | 9.5% | 10.1% | 4.2% | 6.8% | 35.6% | 12.5% | 3.1% | β9.0% |
| Return on equity | 13.3% | 5.9% | 5.6% | 0.6% | 1.8% | 3.9% | 34.2% | 9.2% | 1.3% | β18.4% |
| Return on assets | 9.0% | 4.2% | 4.5% | 0.5% | 1.5% | 3.4% | 29.6% | 8.1% | 0.9% | β12.0% |
| Return on tangible equity | 13.5% | 5.8% | 5.5% | 0.5% | 1.8% | 3.9% | 29.2% | 9.2% | 1.8% | β30.8% |
| Growth | ||||||||||
| Revenue growth | β | 6.7% | β13.5% | 11.4% | 3.2% | 8.9% | 47.5% | β25.5% | β | 70.7% |
| Net income growth | β | β54.1% | 1.0% | β88.7% | 231.6% | 124.9% | 976.8% | β67.8% | β | β1,451.4% |
| EPS growth | β | β60.2% | 0.0% | β88.7% | 200.0% | 127.8% | 958.5% | β67.5% | β | β1,195.8% |
| FCF growth | β | β156.8% | β | β102.3% | β | β | 1,425.4% | β69.3% | β | β |
| Share count change | β | 14.7% | 1.0% | 5.0% | 6.2% | β1.6% | 1.3% | β1.1% | β | 24.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.7x | 0.8x | β0.6x | β1.5x | β2.5x | β1.8x | β1.1x | β2.9x | β0.0x | β |
| Debt / equity | 0.2x | 0.2x | 0.1x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.1x | 0.2x |
| Interest coverage | 4.1x | 15.0x | 11.0x | 52.0x | 28.5x | 50.7x | 1,908.1x | 1,069.8x | 149.8x | β7.2x |
| Current ratio | 2.6x | 3.1x | 4.9x | 7.4x | 7.3x | 6.2x | 7.6x | 10.0x | 3.9x | 3.5x |
| Quick ratio | 1.2x | 1.1x | 2.0x | 3.2x | 3.2x | 2.7x | 4.9x | 6.1x | 1.5x | 1.4x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.0% | 0.8% | 0.5% | 0.9% | 3.1% | 1.0% | 1.0% | 0.7% | 1.8% | 0.3% |
| Stock comp / revenue | 1.3% | 0.6% | 0.3% | 0.4% | 0.8% | β0.4% | 1.1% | 1.4% | 1.3% | 1.8% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 7.0 | 6.0 | 6.0 | 8.0 | 8.0 | 5.0 | β | 2.0 |
| Altman Z'' | 5.9 | 7.8 | 10.5 | 13.1 | 12.9 | 11.6 | 15.5 | 15.7 | 6.4 | 4.6 |
| Accruals ratio | 5.4% | 4.8% | β8.8% | β0.2% | β0.3% | β0.3% | β4.5% | β1.0% | 3.4% | β4.5% |
Source: SEC EDGAR XBRL filings (CIK 0000798081). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.